ISAB meeting 2025

Meeting of the International Scientific Advisory Board (ISAB) of the BRADY Project

Place: Czech Academy of Sciences, Národní 3

On December 10, 2025, a meeting of the International Scientific Advisory Board (ISAB) of the BRADY Project will take place at the Czech Academy of Sciences on Národní třída in Prague.
Members of the International Scientific Council will attend the meeting, the project's expert team led by research project manager Dr. Jaroslav Hlinka from the Institute of Computer Science of the Czech Academy of Sciences, v.v.i., and senior staff from all partner institutions (Czech Technical University, National Institute of Mental Health, Charles University), and all researchers involved in the project implementation are also invited to the meeting.

The program will include, among other things, an annual conference supplemented by expert lectures. The meeting will focus on evaluating the project's results to date and formulating recommendations for its further development and implementation in the coming period. 

In order to ensure the scientific excellence of the BRADY project, an International Scientific Advisory Board (ISAB) has been established. ISAB is an independent advisory body in the area of strategy and evaluation of the work of the project's expert team. The ISAB meets annually to review the progress of the project, the quality of professional project activities and make professional recommendations in all areas covered by the project. 

The following leading foreign scientists serve on the advisory board:

Prof. Daniel Margulies (Google Scholar h-index=74) is a CNRS Research Director at UMR 80002, leading the Integrative Neuroscience & Cognition Center in Paris. He is a leading researcher in the area of the organisation of large scale brain networks, and the analysis of intrinsic activity as measured with functional magnetic resonance imaging. His current research addresses the emergence of network topography and its relation to cortical structure. His expertise is directly relevant to the research under RWP1.

Prof. Andrea Antal, Ph.D. (Google Scholar h-index=69) is a Head of the Department of Clinical Neurophysiology, University Medical Center Göttingen, DE. She is a leading researcher in the field of diagnostics and the treatment of neuropsychiatric disorders using non-invasive Brain Stimulation methods. Her current research addresses the emergence of transcranial alternating current stimulation (tACS). Her expertise is directly relevant to the research under RWP3.

Prof. Karsten Muller (Google Scholar h-index=26)  received degree Dr. habil. in Cognitive Neurology, Faculty of Medicine, Leipzig University. In 2015, he earned the academic title Apl-Professor at the Faculty of Medicine, Leipzig University. His research areas are focused on  investigating changes of human brain function and brain connectivity using functional MRI (fMRI). In particular, he is interested in longitudinal effects of treatment onto brain function and connectivity in neurodegenerative disease.

Dr. Sebastian Olbrich (Google Scholar h-index=24) earned his MD degree at Ludwig Maximilian University of Munich, Germany. He is the Head of the Center for Depression, Anxiety and Psychotherapy, University of Zurich and president of the International Pharmco-EEG Society (IPEG). He is also the co-founder of DeepPsy, a company that offers treatment personalization based on the individual biological profile of patients by analysing EEG and ECG data. His research has mainly focused on prediction in psychiatry using EEG-vigilance biomarker as a validated tool in healthy subjects and patients, suffering from different neuropsychiatric disorders. The resting state vigilance biomarker was used in one of the largest electrophysiological cohorts of depressed patients from the iSPOT-D study to show that the EEG and ECG based markers in a retrospective analysis predicted treatment outcome for SSRI and SNRI treatment (n=1008). Dr. Olbrich used machine learning algorithms to prove the differentiation capabilities of markers using K-means clustering and support vector machines for identification of clinical risk factors for coercion and innovative deep neural networks to classify EEG and ECG data reliably into different groups. Moreover, he also conducted the first systematic review on deep learning techniques and EEG in psychiatric disorders.

Prof. Alain Destexhe (Google Scholar h-index=81) is a Professor and Research Director at the French National Center for Scientfic Research. He is Vice Director of the Paris-Saclay Institute of Neuroscience (NeuroPSI), one of the largest Neuroscience research institutes in France, and he is also the founder and director of the European Institute of Theoretical Neuroscience (EITN). He is a specialist of electrophysiology and computational neuroscience, particularly in the wake-sleep cycle, anesthesia, epilepsy and states of minimal consciousness. These subjects are investigated using a mix of experimental data and computational approaches, from mice to humans. He is also a founding member of the Human Brain Project (10-year European Flagship project, with a 1 billion Euro budget). He was awarded the Silver Medal by CNRS (which awards mid-career scientists) in 2008. He has written 2 monographies, 7 books as editor, and more than 160 articles in peer-reviewed journals.

Dr. Greetje de Kleuver-Westerhof is managing director of Global Scale-up Company helping Dutch start-ups to scale mainly in the US. She maintains a trusted, large network of over 100 contacts in the Life Science and Health sector in California, Boston and Arizona that are of great value for European scaling companies. She was project manager of foreign Investments in life sciences & health in the East Netherlands Development Agency. She was responsible for development and establishment of medical labs for rehabilitation field Before she was working as innovation manager in the  Health Valley incubator in Gelderland.